# US 2010/0062512 A1 · Purification of factor xi

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0062512 A1
- Document ID: US20100062512A1
- Status: Published application
- Kind: A1
- Application number: 12/448,074
- Filed: 2008-01-03
- Published: 2010-03-11
- Earliest claimed: 2007-01-04
- Assignees: Crucell Holland B.V.
- Inventors: Paul H. Markus
- Web page: https://patentgrep.com/patent/US20100062512A1

## CPC

- C07K 14/745: Blood coagulation or fibrinolysis factors
- C12N 9/6443: {Coagulation factor XIa (3.4.21.27)}
- C12N 9/647: {Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups}
- C12Y 304/21027: Coagulation factor XIa (3.4.21.27)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

The invention provides methods for purifying blood coagulation Factor XI from biological fluids, the methods comprising a step of hydrophobic charge induction chromatography (HCIC).

## Claims

### Claim 1

A method for purifying Factor XI from a biological fluid, comprising the steps of:
a) contacting the biological fluid containing Factor XI with an Hydrophobic Charge Induction Chromatography (HCIC) resin to bind Factor XI to said HCIC resin;
b) washing the HCIC resin with a solution to remove contaminants; and
c) eluting Factor XI by treating the HCIC resin with a solution having a pH that is 5.5 or lower.

### Claim 2 (depends on 1)

A method according to claim 1, wherein the HCIC resin is MEP-HyperCel.

### Claim 3 (depends on 1)

The method according to claim 1, wherein step a) is carried out at a pH between 6 and 9.

### Claim 4 (depends on 1)

The method according to claim 1, wherein step b) comprises washing with a solution having a pH between 6 and 9.

### Claim 5 (depends on 4)

A method according to claim 4, wherein said solution having a pH of between 6 and 9 comprises caprylate.

### Claim 6 (depends on 1)

The method according to claim 1, wherein step c) is carried out using a solution that has a pH between 5.5 and 3.

### Claim 7 (depends on 1)

The method according to claim 1, further comprising at least one anion exchange step.

### Claim 8 (depends on 1)

The method according to claim 1, wherein the biological fluid is selected from the group consisting of blood plasma, cell culture supernatants, cell-conditioned culture medium and fractions derived from an earlier chromatographic separation step.

### Claim 9 (depends on 1)

The method according to claim 1, wherein said Factor XI has been recombinantly expressed.

### Claim 10

A method of purifying Factor XI from a biological fluid, wherein the improvement comprises:
utilizing a Hydrophobic Charge Induction Chromatography resin for the purification of Factor XI from the biological fluid.

### Claim 11 (depends on 2)

The method according to claim 2, wherein step a) is carried out at a pH between 6 and 9.

### Claim 12 (depends on 2)

The method according to claim 2, wherein step b) comprises washing with a solution having a pH between 6 and 9.

### Claim 13 (depends on 12)

The method according to claim 12, wherein the solution having a pH of between 6 and 9 comprises caprylate.

### Claim 14 (depends on 2)

The method according to claim 2, wherein step c) is carried out using a solution that has a pH of between 5.5 and 3.

### Claim 15 (depends on 2)

The method according to claim 2, further comprising at least one anion exchange step.

### Claim 16

A method for purifying Factor XI from a biological fluid, wherein the Factor XI does not exhibit undesired activation during performance of the method, the method comprising:
contacting the biological fluid with a hydrophobic charge induction chromatography (HCIC) resin at a pH of between 6 and 9 so as to bind Factor XI to the HCIC resin;
washing the resulting HCIC resin with a solution at a pH of between 6 and 9 to remove contaminants; and
eluting Factor XI therefrom by treating the HCIC resin with a solution having a pH of between 3 and 5.5,
thus purifying Factor XI from the biological fluid, which Factor XI can be activated in a clotting assay.

### Claim 17 (depends on 16)

The method according to claim 16, wherein the HCIC resin comprises 4-mercapto-ethyl-pyridine.

### Claim 18 (depends on 16)

The method according to claim 16, further comprising anion exchange.

### Claim 19 (depends on 16)

The method according to claim 16, wherein the biological fluid is selected from the group consisting of blood plasma, cell culture supernatants, and cell-conditioned culture medium.
